AbbVie (ABBV) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Landos Biopharma, Inc. (LABP)
Company Research
Source: Yahoo! Finance
Call Participants Prepared Remarks: Operator Good morning and thank you for standing by. Welcome to the AbbVie first quarter 2024 earnings conference call. All participants will be able to listen-only until the question-and-answer portion of this call. [Operator instructions] Today's call is also being recorded. If you have any objections, you may disconnect at this time. I would now like to introduce Ms. Liz Shea, senior vice president of investor relations. Ma'am, you may begin. Liz Shea Vice President, Investor Relations Good morning, and thanks for joining us. Also, on the call with me today are Rick Gonzalez, chairman of the board and chief executive officer; Rob Michael, president and chief operating officer; Jeff Stewart, executive vice president, chief commercial officer; Scott Reents, executive vice president, chief financial officer; Carrie Strom, senior vice president, AbbVie and president, global Allergan Aesthetics; and Roopal Thakkar, senior vice president,
Show less
Read more
Impact Snapshot
Event Time:
LABP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LABP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LABP alerts
High impacting Landos Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
LABP
News
- Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbViePR Newswire
- SHAREHOLDER ALERT: Weiss Law Investigates Landos Biopharma, Inc.Accesswire
- Landos Biopharma, Inc. (NASDAQ: LABP) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $20.42 price target on the stock, down previously from $50.00.MarketBeat
- LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABPBusiness Wire
- SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates LABP, WRK, TGAN, KAMNAccesswire
LABP
Analyst Actions
- 4/1/24 - HC Wainwright
LABP
Sec Filings
- 5/9/24 - Form 10-Q
- 4/25/24 - Form DEFM14A
- 4/16/24 - Form 10-K/A
- LABP's page on the SEC website